Jia‐Bo Zheng

935 total citations · 1 hit paper
20 papers, 625 citations indexed

About

Jia‐Bo Zheng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Jia‐Bo Zheng has authored 20 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Jia‐Bo Zheng's work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Jia‐Bo Zheng is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Jia‐Bo Zheng collaborates with scholars based in China, United States and United Kingdom. Jia‐Bo Zheng's co-authors include Rui‐Hua Xu, Hui Luo, Ziyi Ye, Wei Wei, Huai‐Qiang Ju, Xiao-Jing Luo, Qi Zhao, Jia Liu, Miao‐Zhen Qiu and Zexian Liu and has published in prestigious journals such as Cancer Research, Gut and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jia‐Bo Zheng

19 papers receiving 623 citations

Hit Papers

Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jia‐Bo Zheng China 11 388 333 146 119 75 20 625
Mariangela Balistreri Italy 10 270 0.7× 219 0.7× 124 0.8× 89 0.7× 72 1.0× 15 487
Princy Francis United States 12 352 0.9× 236 0.7× 180 1.2× 228 1.9× 34 0.5× 16 627
Masahisa Ohtsuka Japan 11 367 0.9× 317 1.0× 136 0.9× 60 0.5× 97 1.3× 48 574
Maura B. Cotter Ireland 8 315 0.8× 226 0.7× 109 0.7× 80 0.7× 40 0.5× 20 472
Tiantian Zhen China 12 328 0.8× 259 0.8× 131 0.9× 113 0.9× 41 0.5× 27 525
Yawei Yuan China 14 314 0.8× 218 0.7× 241 1.7× 190 1.6× 126 1.7× 25 679
Xiujuan Han China 15 317 0.8× 158 0.5× 141 1.0× 53 0.4× 63 0.8× 35 525
Daniela Morales-Espinosa Spain 12 206 0.5× 155 0.5× 276 1.9× 190 1.6× 30 0.4× 25 534
Yoko Karube Japan 12 459 1.2× 443 1.3× 127 0.9× 167 1.4× 96 1.3× 36 781
Yingqi Zhou China 12 358 0.9× 225 0.7× 204 1.4× 65 0.5× 112 1.5× 20 577

Countries citing papers authored by Jia‐Bo Zheng

Since Specialization
Citations

This map shows the geographic impact of Jia‐Bo Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia‐Bo Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia‐Bo Zheng more than expected).

Fields of papers citing papers by Jia‐Bo Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia‐Bo Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia‐Bo Zheng. The network helps show where Jia‐Bo Zheng may publish in the future.

Co-authorship network of co-authors of Jia‐Bo Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jia‐Bo Zheng. A scholar is included among the top collaborators of Jia‐Bo Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia‐Bo Zheng. Jia‐Bo Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Huashe, Jun Liu, Xiaochuan Chen, et al.. (2025). Combined MDM2 and G2/M checkpoint inhibition induces synergistic antitumor response in gastric signet-ring cell carcinoma. Cancer Letters. 613. 217500–217500. 2 indexed citations
2.
Cai, Zerong, Yongqiang Zheng, Yan Hu, et al.. (2025). Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study. Gut. 74(6). 884–893. 12 indexed citations
4.
5.
Liu, Jia, Xiaojing Luo, Yan‐Xing Chen, et al.. (2023). Long noncoding RNA Regulating ImMune Escape regulates mixed lineage leukaemia protein‐1‐H3K4me3‐mediated immune escape in oesophageal squamous cell carcinoma. Clinical and Translational Medicine. 13(9). e1410–e1410. 30 indexed citations
6.
Chen, Huaxian, Zijian Deng, Jia‐Bo Zheng, et al.. (2023). Implication of perineural invasion in patients with stage II gastric cancer. World Journal of Surgical Oncology. 21(1). 372–372. 6 indexed citations
7.
Luo, Xiaojing, Ming-Ming He, Jia Liu, et al.. (2022). LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcription. Experimental & Molecular Medicine. 54(6). 834–847. 24 indexed citations
8.
Liu, Zexian, Zhao-Lei Zeng, Xiao-Jing Luo, et al.. (2022). The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer. Cancer Research. 83(9). 1476–1489. 37 indexed citations
9.
Zheng, Jia‐Bo, Jia Liu, Xiaojing Luo, et al.. (2022). Glucose metabolism inhibitor PFK-015 combined with immune checkpoint inhibitor is an effective treatment regimen in cancer. OncoImmunology. 11(1). 2079182–2079182. 20 indexed citations
10.
Wu, Qi‐Nian, Xiao-Jing Luo, Jia Liu, et al.. (2021). MYC-Activated LncRNA MNX1-AS1 Promotes the Progression of Colorectal Cancer by Stabilizing YB1. Cancer Research. 81(10). 2636–2650. 59 indexed citations
11.
Luo, Hui, Wei Wei, Ziyi Ye, Jia‐Bo Zheng, & Rui‐Hua Xu. (2021). Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA. Trends in Molecular Medicine. 27(5). 482–500. 210 indexed citations breakdown →
12.
Zeng, Zhao-Lei, Jia-Huan Lu, Yun Wang, et al.. (2021). The lncRNA XIST/miR‐125b‐2‐3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer. Cancer Medicine. 10(7). 2423–2441. 30 indexed citations
13.
Luo, Xiao-Jing, Qi Zhao, Jia Liu, et al.. (2020). Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer. Molecular Therapy. 29(2). 587–596. 92 indexed citations
15.
Fan, Ningbo, Dongni Chen, Jia‐Bo Zheng, Zhesheng Wen, & Peng Lin. (2019). <p>A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio</p>. Cancer Management and Research. Volume 11. 4719–4728. 10 indexed citations
16.
Fan, Ningbo, Han Yang, Jia‐Bo Zheng, et al.. (2019). Comparison of short- and long-term outcomes between 3-field and modern 2-field lymph node dissections for thoracic oesophageal squamous cell carcinoma: a propensity score matching analysis. Interactive Cardiovascular and Thoracic Surgery. 29(3). 434–441. 8 indexed citations
19.
Kapur, Sunil, Gary L. Aistrup, James E. Kelly, et al.. (2010). Early development of intracellular calcium cycling defects in intact hearts of spontaneously hypertensive rats. American Journal of Physiology-Heart and Circulatory Physiology. 299(6). H1843–H1853. 30 indexed citations
20.
Wasserstrom, J. Andrew, Jia‐Bo Zheng, James E. Kelly, et al.. (2009). Ranolazine Antagonizes the Effects of Increased Late Sodium Current on Intracellular Calcium Cycling in Rat Isolated Intact Heart. Journal of Pharmacology and Experimental Therapeutics. 331(2). 382–391. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026